Intracerebral Hemorrhage. New Challenges and Steps Forward.

Jose Javier Provencio*, Ivan Rocha Ferreira Da Silva, Edward Michael Manno

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


Intracerebral hemorrhage (ICH) is a significant cause of morbidity and mortality. With the aging population, increased use of anticoagulants, and changing racial and ethnic landscape of the United States, the incidence of ICH will increase over the next decade. Improvements in preventative strategies to treat hypertension and atrial fibrillation are necessary to change the trajectory of this increase. Advances in the understanding of ICH at the vascular and molecular level may pave the way to new treatment options. This article discusses the epidemiology, pathophysiology, and current treatment options for patients with ICH. Differences in outcome and treatment between patients taking and not taking anticoagulant therapies are considered.

Original languageEnglish (US)
Pages (from-to)349-359
Number of pages11
JournalNeurosurgery clinics of North America
Issue number3
StatePublished - Jul 2013


  • Acute brain injury
  • Anticoagulation
  • Intracerebral hemorrhage

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology


Dive into the research topics of 'Intracerebral Hemorrhage. New Challenges and Steps Forward.'. Together they form a unique fingerprint.

Cite this